|
2021
|
Invention
|
Pharmaceutical combination for the treatment of liver diseases. The invention relates to a pharma... |
|
|
Invention
|
Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disea... |
|
|
Invention
|
Use of a thienopyridone derivative in the treatment of cardiovascular diseases. The invention rel... |
|
|
Invention
|
Use of a thienopyridone derivative in the treatment of diabetic nephropathy.
The invention relat... |
|
|
Invention
|
Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropa... |
|
|
Invention
|
Use of a thienopyridone derivative in the treatment of diabetic nephropathy. Use of a thienopyrid... |
|
2020
|
Invention
|
Pharmaceutical combination of a specific thienopyridone derivative with an fxr agonist for the tr... |
|
2019
|
Invention
|
Monohydrate potassium salt of a thienopyridone derivative and its preparation process.
The inven... |
|
|
Invention
|
Monohydrate potassium salt of a thienopyridone derivative and its preparation process. Monohydrat... |
|
|
Invention
|
Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes. This in... |
|
2018
|
Invention
|
Methods of treating heart failure with preserved ejection fraction. The present invention provide... |
|
|
Invention
|
Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection. The pre... |
|
2017
|
G/S
|
Pharmaceutical products for the treatment of diabetes, metabolic diseases, mitochondrial dysfunct... |
|
|
G/S
|
Pharmaceutical products and preparations. Development of pharmaceutical preparations, pharmaceuti... |
|
|
G/S
|
Development of pharmaceutical preparations, pharmaceutical products and medicines; evaluation of ... |
|
2014
|
G/S
|
Advertisement services, Management of business affairs, Business administration, Office functions... |
|
|
G/S
|
Advertisement services, Business management, Business management, Office functions. Scientific an... |
|
2013
|
Invention
|
Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled c... |
|
|
Invention
|
Thienopyridone derivatives useful as activators of ampk. Activators of AMPK and therapeutic uses ... |
|
2011
|
Invention
|
Separation of triazine derivatives enantiomers using tartaric acid. The present invention relates... |
|
|
Invention
|
Treatment of type 2 diabetes.
The present invention relates to triazine derivatives of Formula I... |
|
|
Invention
|
Treatment of type 1 diabetes. The present invention relates to triazine derivatives of formula (I... |
|
|
Invention
|
Treatment of type 2 diabetes. The present invention relates to triazine derivatives of Formule I ... |
|
2010
|
Invention
|
Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof. The invention relat... |
|
|
Invention
|
Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion ... |
|
|
Invention
|
Amino derivatives of dihydro-1,3,5-triazine for treating oxidative stress. The present invention ... |
|
|
Invention
|
Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystalli... |
|
|
G/S
|
Advertising services, business management, business
administration, office functions. Scientific... |
|
2009
|
Invention
|
Tetrahydrotriazine compounds for treating diseases associated with ampk activity. 6 have the mean... |
|
|
Invention
|
Tetrahydrotriazine compounds for treating diseases associated with ampk activity. The invention r... |
|
|
Invention
|
Process of isolating enantiomer component from enantiomer mixtures by particle-size-controlled cr... |
